ADVERTISEMENT

ESC 2022 — Effect of comprehensive image-based cardiovascular screening on all-cause mortality

Shrabasti Bhattacharya   |   Conference Report   |   01 September 2022
ADVERTISEMENT

Takeaway

  • The Danish Cardiovascular Screening (DANCAVAS) trial did not show any benefit of comprehensive image-based cardiovascular (CV) screening on all-cause mortality among men aged 65-74 years; however, sub-group analysis revealed the benefits of screening among the younger participants (age, 65-69 years).

Why this matters

  • CV diseases are the main cause...

          

January Challenge

Ends in 2d 1h
left
right

Topic Challenges

left
right